Abstract
The oculomotor system is known to engage key structures within the basal ganglia and respond to dopaminergic stimulation. Therefore, it is unsurprising that Parkinson’s disease (PD) should be associated with distinctive abnormalities of eye movement generation and control. Briefly outlined is the functional neuroanatomy of the oculomotor system, then the examination of the abnormalities seen in PD, their value in the differential diagnosis of Parkinsonism, and their response to pharmacological and surgical treatment are discussed. The chapter concludes with a novel hypothesis that attempts to reconcile saccadic hypometria, the most characteristic oculomotor deficit in PD, with current models of basal ganglia function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sparks DL. The brainstem control of saccadic eye movements. Nat Rev Neurosci 2002;3:952–964.
Moschovakis AK, Scudder CA, Highstein SM. The microscopic anatomy and physiology of the mammalian saccadic system. Prog Neurobiol 1996;50:133–254.
Tehovnik EJ, Sommer MA, Chou IH, et al. Eye fields in the frontal lobes of primates. Brain Res Brain Res Rev 2000;32:413–448.
Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000;80:953–978.
Takikawa Y, Kawagoe R, Hikosaka O. Reward-dependent spatial selectivity of anticipatory activity in monkey caudate neurons. J Neurophysiol 2002;87:508–515.
Lauwereyns J, Takikawa Y, Kawagoe R, et al. Feature-based anticipation of cues that predict reward in monkey caudate nucleus. Neuron 2002;33:463–473.
Lauwereyns J, Watanabe K, Coe B, Hikosaka O. A neural correlate of response bias in monkey caudate nucleus. Nature 2002;418:413–417.
Takikawa Y, Kawagoe R, Itoh H, et al. Modulation of saccadic eye movements by predicted reward outcome. Exp Brain Res 2002;142:284–291.
Hotson JR, Langston EB, Langston JW. Saccade responses to dopamine in human MPTP-induced Parkinsonism. Ann Neurol 1986;20:456–463.
Brooks BA, Fuchs AF, Finocchio D. Saccadic eye movement deficits in the MPTP monkey model of Parkinson’s disease. Brain Res 1986;383:402–407.
Schultz W, Romo R, Scarnati E, et al. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Exp Brain Res 1989;78:253–267.
Grace AA, Bunney BS. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization. Neuroscience 1983;10:301–315.
Kato M, Miyashita N, Hikosaka O, et al. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades. J Neurosci 1995;15:912–927.
Miyashita N, Hikosaka O, Kato M. Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys. Neuroreport 1995;6:1257–1260.
Krauzlis RJ, Stone LS. Tracking with the mind’s eye. Trends Neurosci 1999;22:544–550.
Seno H, Kobayashi S, Inagaki T, et al. Parkinson’s disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case. J Neurol Sci 2000;178:70–74.
Highstein S, Cohen B, Mones R. Changes in saccadic eye movements of patients with Parkinson’s disease before and after L-dopa. Trans Am Neurol Assoc 1969;94:277–279.
Teravainen H, Calne DB. Studies of parkinsonian movement:1. Programming and execution of eye movements. Acta Neurol Scand 1980;62:137–148.
DeJong JD, Jones GM. Akinesia, hypokinesia, and bradykinesia in the oculomotor system of patients with Parkinson’s disease. Exp Neurol 1971;32:58–68.
Shibasaki H, Tsuji S, Kuroiwa Y. Oculomotor abnormalities in Parkinson’s disease. Arch Neurol 1979;36:360–364.
Crawford T, Goodrich S, Henderson L, Kennard C. Predictive responses in Parkinson’s disease: manual keypresses and saccadic eye movements to regular stimulus events. J Neurol Neurosurg Psychiatry 1989;52: 1033–1042.
Bronstein AM, Kennard C. Predictive ocular motor control in Parkinson’s disease. Brain 1985; 108:925–940.
Ventre J, Zee DS, Papageorgiou H, Reich S. Abnormalities of predictive saccades in hemi-Parkinson’s disease. Brain 1992;115:1147–1165.
Crawford TJ, Henderson L, Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson’s disease. Brain 1989;112:1573–1586.
Kitagawa M, Fukushima J, Tashiro K. Relationship between antisaccades and the clinical symptoms in Parkinson’s disease. Neurology 1994;44:2285–2289.
Lueck CJ, Tanyeri S, Crawford TJ, et al. Antisaccades and remembered saccades in Parkinson’s disease. J Neurol. Neurosurg Psychiatry 1990;53:284–288.
Lueck CJ, Crawford TJ, Henderson L, et al. Saccadic eye movements in Parkinson’s disease: II. Remembered saccades—towards a unified hypothesis? Q J Exp Psychol A 1992;45:211–233.
Nakamura T, Bronstein AM, Lueck C, et al. Vestibular, cervical and visual remembered saccades in Parkinson’s disease. Brain 1994;117:1423–1432.
Shaunak S, O’Sullivan E, Blunt S, et al. Remembered saccades with variable delay in Parkinson’s disease. Mov Disord 1999;14:80–86.
Kimmig H, Haussmann K, Mergner T, Lucking CH. What is pathological with gaze shift fragmentation in Parkinson’s disease? J Neurol 2002;249:683–692.
Vermersch AI, Rivaud S, Vidailhet M, et al. Sequences of memory-guided saccades in Parkinson’s disease. Ann Neurol 1994;35:487–490.
Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 1994;71:515–528.
O’Sullivan EP, Shaunak S, Henderson L, et al. Abnormalities of predictive saccades in Parkinson’s disease. Neuroreport 1997;8:1209–1213.
Hodgson TL, Dittrich WH, Henderson L, Kennard C. Eye movements and spatial working memory in Parkinson’s disease. Neuropsychologia 1999;37:927–938.
Hodgson TL, Tiesman B, Owen AM, Kennard C. Abnormal gaze strategies during problem solving in Parkinson’s disease. Neuropsychologia 2002;40:411–422.
Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420–426.
Fukushima J, Fukushima K, Miyasaka K, Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics. Biol Psychiatry 1994;36:21–30.
Roll A, Wierzbicka MM, Wolf W. The “gap paradigm” leads to express-like saccadic reaction times in Parkinson’s disease. Exp Brain Res 1996;111:131–138.
Briand KA, Hening W, Poizner H, Sereno AB. Automatic orienting of visuospatial attention in Parkinson’s disease. Neuropsychologia 2001;39:1240–1249.
Mort DJ, Perry RJ, Mannan SK, et al. Differential cortical activation during voluntary and reflexive saccades in man. Neuroimage 2003;18:231–246.
Deubel H. Separate adaptive mechanisms for the control of reactive and volitional saccadic eye movements. Vision Res 1995;35:3529–3540.
Crevits L, De Ridder K. Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients. J Neurol Neurosurg Psychiatry 1997;63:296–299.
Briand KA, Strallow D, Hening W, et al. Control of voluntary and reflexive saccades in Parkinson’s disease. Exp Brain Res 1999;129:38–48.
Gibson JM, Pimlott R, Kennard C. Ocular motor and manual tracking in Parkinson’s disease and the effect of treatment. J Neurol Neurosurg Psychiatry 1987;50:853–860.
Rascol O, Clanet M, Montastruc JL, et al. Abnormal ocular movements in Parkinson’s disease. Evidence for involvement of dopaminergic systems. Brain 1989;112:1193–1214.
Rivaud-Pechoux S, Vermersch AI, Gaymard B, et al. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2000;68:381–384.
Straube A, Ditterich J, Oertel W, Kupsch A. Electrical stimulation of the posteroventral pallidum influences internally guided saccades in Parkinson’s disease. J Neurol 1998;245:101–105.
White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA. Ocular motor deficits in Parkinson’s disease. II. Control of the saccadic and smooth pursuit systems. Brain 1983;106:571–587.
Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson’s disease. J Neurol Sci 1972;15:251–265.
Gibson JM, Kennard C. Quantitative study of “on-off” fluctuations in the ocular motor system in Parkinson’s disease. Adv Neurol 1987;45:329–333.
Sharpe JA, Fletcher WA, Lang AE, Zackon DH. Smooth, pursuit during dose-related on-off fluctuations in Parkinson’s disease. Neurology 1987;37:1389–1392.
Waterston JA, Barnes GR, Grealy MA, Collins S. Abnormalities of smooth eye and head movement control in Parkinson’s disease. Ann Neurol 1996;39:749–760.
Bares M, Brazdil M, Kanovsky P, et al. The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord 2003;9:139–144.
Krack P, Marion MH. “Apraxia of lid opening,” a focal eyelid dystonia: clinical study of 32 patients. Mov Disord 1994;9:610–615.
Hirayama M, Kumano T, Aita T, et al. Improvement of apraxia of eyelid opening by wearing goggles. Lancet 2000;356:1413.
Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson’s disease responsive to levodopa. Strabismus 1999;7:169–174.
de Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, Parkinsonism, and dementia: a case report. Mov Disord 1992;7:355–358.
Fearnley JM, Revesz T, Brooks DJ, et al. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 1991;54:159–161.
Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology. Arch Neurol 2002;59:464–467.
Lewis AJ, Gawel MJ. Diffuse Lewy body disease with dementia and oculomotor dysfunction. Mov Disord 1990;5:143–147.
Cordato NJ, Halliday GM, McCann H, et al. Corticobasal syndrome with tau pathology. Mov Disord 2001; 16:656–667.
Oyanagi K, Chen KM, Craig UK, et al. Parkinsonism, dementia and vertical gaze palsy in a Guamanian with atypical neuroglial degeneration. Acta Neuropathol. (Berl) 2000;99:73–80.
Averbuch-Heller L, Paulson GW, Daroff RB, Leigh RJ. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999;66:532–535.
Averbuch-Heller L, Helmchen C, Horn AK, et al. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol 1998;44:641–648.
Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic Parkinsonism. J Neural Transm 1997;104:845–865.
Grant MP, Cohen M, Petersen RB, et al. Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol 1993;34:192–197.
Zarei M, Nouraei SA, Caine D, et al. Neuropsychological and quantitative oculometric study of a case of sporadic Creutzfeldt-Jakob disease at predementia stage. J Neurol Neurosurg Psychiatry 2002;73:56–58.
Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117:1183–1196.
Merchut MP, Brigell M. Olivopontocerebellar atrophy presenting with hemiparkinsonian ocular motor signs. J Clin Neuroophthalmol 1990;10:210–214.
Rottach KG, Riley DE, DiScenna AO, et al. Dynamic, properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 1996;39:368–377.
Shimizu N, Cohen B, Bala SP, et al. Ocular dyskinesias in patients with Parkinson’s disease treated with levodopa. Ann Neurol 1977;1:167–171.
Linazasoro G, Van Blercom N, Lasa A, et al. Levodopa-induced ocular dyskinesias in Parkinson’s disease. Mov Disord 2002;17:186–187.
Blekher T, Siemers E, Abel LA, Yee RD. Eye movements in Parkinson’s disease: before and after pallidotomy. Invest Ophthalmol Vis Sci 2000;41:2177–2183.
Averbuch-Heller L, Stahl JS, Hlavin ML, Leigh RJ. Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology 1999;52:185–188.
Anagnostou E, Sporer B, Steude U, et al. Contraversive eye deviation during deep brain stimulation of the globus pallidus internus. Neurology 2001;56:1396–1399.
Harris CM. Does saccadic undershoot minimize saccadic flight-time? A Monte-Carlo study. Vision Res 1995; 35:691–701.
Straube A, Deubel H, Ditterich J, Eggert T. Cerebellar lesions impair rapid saccade amplitude adaptation. Neurology 2001;57:2105–2108.
Desmurget M, Pelisson D, Urquizar C, et al. Functional anatomy of saccadic adaptation in humans. Nat Neurosci 1998;1:524–528.
Desmurget M, Pelisson D, Grethe JS, et al. Functional adaptation of reactive saccades in humans: a PET study. Exp Brain Res 2000;132:243–259.
Straube A, Fuchs AF, Usher S, Robinson FR. Characteristics of saccadic gain adaptation in rhesus macaques. J Neurophysiol 1997;77:874–895.
Robinson FR, Noto CT, Bevans SE. Effect of Visual Error Size on Saccade Adaptation in Monkey. J Neurophysiol 2003;90:1235–1244.
Ketcham CJ, Hodgson TL, Kennard C, Stelmach GE. Memory-motor transformations are impaired in Parkinson’s disease. Exp Brain Res 2003;149:30–39.
Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996;50:381–425.
McAuley JH. The physiological basis of clinical deficits in Parkinson’s disease. Prog Neurobiol 2003;69:27–48.
Meunier S, Pol S, Houeto JL, Vidailhet M. Abnormal reciprocal inhibition between antagonist muscles in Parkinson’s disease. Brain 2000;123:1017–1026.
Jiang H, Stein BE, McHaffie JG. Opposing basal ganglia processes shape midbrain visuomotor activity bilaterally. Nature 2003;423:982–986.
MacAskill MR, Anderson TJ, Jones RD. Adaptive modification of saccade amplitude in Parkinson’s disease. Brain 2002;125:1570–1582.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Nachev, P., Kennard, C. (2005). Oculomotor Dysfunction. In: Pfeiffer, R.F., Bodis-Wollner, I. (eds) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-859-5:271
Download citation
DOI: https://doi.org/10.1385/1-59259-859-5:271
Publisher Name: Humana Press
Print ISBN: 978-1-58829-316-9
Online ISBN: 978-1-59259-859-5
eBook Packages: MedicineMedicine (R0)